Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
Niels J. M. Verstegen, Ruth R Hagen, Jet van den Dijssel, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 20

Showing 20 citing articles:

mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
Jet van den Dijssel, Mariël C Duurland, Veronique A. L. Konijn, et al.
Journal of Autoimmunity (2024) Vol. 144, pp. 103175-103175
Open Access | Times Cited: 3
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
Niels J. M. Verstegen, Ruth R Hagen, Christine Kreher, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024) Vol. 95, Iss. 9, pp. 855-864
Open Access | Times Cited: 3
Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis
Zoé L.E. van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Annals of Neurology (2022) Vol. 93, Iss. 1, pp. 103-108
Open Access | Times Cited: 12
Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection
Anis Barmada, Louis‐François Handfield, Gerard Godoy‐Tena, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 1
Open Access | Times Cited: 7
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan Volkers, Luuk Wieske, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
SARS-CoV-2 mRNA vaccine-induced immune responses in rheumatoid arthritis
Marc-André Limoges, Audrey Lortie, Élodie Demontier, et al.
Journal of Leukocyte Biology (2023) Vol. 114, Iss. 4, pp. 358-367
Open Access | Times Cited: 5
T follicular helper cell responses to SARS‐CoV ‐2 vaccination among healthy and immunocompromised adults
Mollie Ailie Acheson Boyd, Alexandra Carey Hoppé, Anthony D. Kelleher, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 6, pp. 504-513
Open Access | Times Cited: 4
Impact of methotrexate on humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
Masahiro Shirata, Isao Ito, Masao Tanaka, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4707-4720
Closed Access | Times Cited: 4
Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy
Christina Woopen, Marie Dunsche, Georges Katoul Al Rahbani, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1464-1464
Open Access | Times Cited: 3
A unique human cord blood CD8+CD45RA+CD27+CD161+T cell subset identified by flow cytometric data analysis using Seurat
Julen Gabirel Araneta Reyes, Duan Ni, Brigitte Santner‐Nanan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
A unique human cord blood CD8 + CD45RA + CD27 + CD161 + T cell subset identified by flow cytometric data analysis using Seurat
Duan Ni, Julen Gabirel Araneta Reyes, Brigitte Santner‐Nanan, et al.
Authorea (Authorea) (2024)
Open Access
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
Eileen W Stalman, Luuk Wieske, Jim Keijser, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 3, pp. 754-766.e7
Open Access
A unique human cord blood CD8+CD45RA+CD27+CD161+ T‐cell subset identified by flow cytometric data analysis using Seurat
Julen Gabirel Araneta Reyes, Duan Ni, Brigitte Santner‐Nanan, et al.
Immunology (2024) Vol. 173, Iss. 1, pp. 106-124
Open Access
Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
European Journal of Neurology (2024)
Open Access
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection
Lisan H. Kuijper, Christine Kreher, George Elias, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients – Lessons learned from the COVID-19 pandemic
Jakub Wroński, Marzena Ciechomska, Ewa Kuca-Warnawin
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115254-115254
Open Access | Times Cited: 1
Vaccination responses in B‐cell‐depleted multiple sclerosis patients: The role of drug pharmacokinetics
Joep Killestein, Zoé L.E. van Kempen
European Journal of Neurology (2022) Vol. 29, Iss. 11, pp. 3137-3138
Open Access | Times Cited: 1
Immunosuppressive therapy selectively modulates B‐cell responses in patients with rheumatic and musculoskeletal diseases receiving the inactivated COVID‐19 vaccine
Rui Li, Ruru Guo, Jia Li, et al.
Rheumatology & autoimmunity (2023) Vol. 3, Iss. 2, pp. 78-89
Open Access
Treatment with natalizumab and ocrelizumab in multiple sclerosis
Alyssa A Toorop
(2023)
Open Access
Longitudinal Dynamics of the SARS-CoV-2 Antibody Repertoire after SARS-CoV-2 Delta and Omicron Breakthrough Infections in Patients with Immune-Mediated Inflammatory Diseases
Eileen W Stalman, Luuk Wieske, Jim Keijser, et al.
(2023)
Closed Access
Page 1

Scroll to top